Skip to main navigation
Cardiff Oncology, Inc. logo
  • Overview
  • News & Events
    • Press Releases
    • Events
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Management Team
    • Committee Composition
    • Ethics and Compliance Hotline
  • Financial Information
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Information Request

Event Details

CRDF-004 First-Line RAS-mutated mCRC Trial Update

July 29, 2025 4:30 PM EDT

Click here for webcast

Supporting Materials

Download Presentation 1.6 MB

Contact Investor Relations

drafts IR@cardiffoncology.com
© Cardiff Oncology, Inc. All rights reserved.

Social Media

  • LinkedIn opens in new window
Search Investors